241 related articles for article (PubMed ID: 22334016)
1. Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity.
Suerth JD; Maetzig T; Brugman MH; Heinz N; Appelt JU; Kaufmann KB; Schmidt M; Grez M; Modlich U; Baum C; Schambach A
Mol Ther; 2012 May; 20(5):1022-32. PubMed ID: 22334016
[TBL] [Abstract][Full Text] [Related]
2. Self-inactivating alpharetroviral vectors with a split-packaging design.
Suerth JD; Maetzig T; Galla M; Baum C; Schambach A
J Virol; 2010 Jul; 84(13):6626-35. PubMed ID: 20410274
[TBL] [Abstract][Full Text] [Related]
3. Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.
Kaufmann KB; Brendel C; Suerth JD; Mueller-Kuller U; Chen-Wichmann L; Schwäble J; Pahujani S; Kunkel H; Schambach A; Baum C; Grez M
Mol Ther; 2013 Mar; 21(3):648-61. PubMed ID: 23207695
[TBL] [Abstract][Full Text] [Related]
4. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
Schambach A; Bohne J; Chandra S; Will E; Margison GP; Williams DA; Baum C
Mol Ther; 2006 Feb; 13(2):391-400. PubMed ID: 16226060
[TBL] [Abstract][Full Text] [Related]
5. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
6. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells.
Cui Y; Golob J; Kelleher E; Ye Z; Pardoll D; Cheng L
Blood; 2002 Jan; 99(2):399-408. PubMed ID: 11781219
[TBL] [Abstract][Full Text] [Related]
7. Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral LTR vector.
Cornils K; Bartholomae CC; Thielecke L; Lange C; Arens A; Glauche I; Mock U; Riecken K; Gerdes S; von Kalle C; Schmidt M; Roeder I; Fehse B
Exp Hematol; 2013 Jan; 41(1):28-38.e3. PubMed ID: 22989760
[TBL] [Abstract][Full Text] [Related]
8. Stable marking and transgene expression without progression to monoclonality in canine long-term hematopoietic repopulating cells transduced with lentiviral vectors.
Enssle J; Trobridge GD; Keyser KA; Ironside C; Beard BC; Kiem HP
Hum Gene Ther; 2010 Apr; 21(4):397-403. PubMed ID: 19947827
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral Vector Promoter is Decisive for Aberrant Transcript Formation.
Scholz SJ; Fronza R; Bartholomä CC; Cesana D; Montini E; von Kalle C; Gil-Farina I; Schmidt M
Hum Gene Ther; 2017 Oct; 28(10):875-885. PubMed ID: 28825370
[TBL] [Abstract][Full Text] [Related]
10. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.
Modlich U; Navarro S; Zychlinski D; Maetzig T; Knoess S; Brugman MH; Schambach A; Charrier S; Galy A; Thrasher AJ; Bueren J; Baum C
Mol Ther; 2009 Nov; 17(11):1919-28. PubMed ID: 19672245
[TBL] [Abstract][Full Text] [Related]
11. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy.
Montini E; Cesana D; Schmidt M; Sanvito F; Bartholomae CC; Ranzani M; Benedicenti F; Sergi LS; Ambrosi A; Ponzoni M; Doglioni C; Di Serio C; von Kalle C; Naldini L
J Clin Invest; 2009 Apr; 119(4):964-75. PubMed ID: 19307726
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells.
Yu X; Zhan X; D'Costa J; Tanavde VM; Ye Z; Peng T; Malehorn MT; Yang X; Civin CI; Cheng L
Mol Ther; 2003 Jun; 7(6):827-38. PubMed ID: 12788657
[TBL] [Abstract][Full Text] [Related]
13. Analysis of self-inactivating lentiviral vector integration sites and flanking gene expression in human peripheral blood progenitor cells after alkylator chemotherapy.
Grund N; Maier P; Giordano FA; Appelt JU; Zucknick M; Li L; Wenz F; Zeller WJ; Fruehauf S; Allgayer H; Laufs S
Hum Gene Ther; 2010 Aug; 21(8):943-56. PubMed ID: 20210626
[TBL] [Abstract][Full Text] [Related]
14. Reduced genotoxicity of avian sarcoma leukosis virus vectors in rhesus long-term repopulating cells compared to standard murine retrovirus vectors.
Hu J; Renaud G; Gomes TJ; Ferris A; Hendrie PC; Donahue RE; Hughes SH; Wolfsberg TG; Russell DW; Dunbar CE
Mol Ther; 2008 Sep; 16(9):1617-23. PubMed ID: 18578011
[TBL] [Abstract][Full Text] [Related]
15. Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform.
Hübner J; Hoseini SS; Suerth JD; Hoffmann D; Maluski M; Herbst J; Maul H; Ghosh A; Eiz-Vesper B; Yuan Q; Ott M; Heuser M; Schambach A; Sauer MG
Mol Ther; 2016 Aug; 24(7):1216-26. PubMed ID: 27138041
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral vector integration sites in human NOD/SCID repopulating cells.
Laufs S; Guenechea G; Gonzalez-Murillo A; Zsuzsanna Nagy K; Luz Lozano M; del Val C; Jonnakuty S; Hotz-Wagenblatt A; Jens Zeller W; Bueren JA; Fruehauf S
J Gene Med; 2006 Oct; 8(10):1197-207. PubMed ID: 16960916
[TBL] [Abstract][Full Text] [Related]
17. Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes.
Labenski V; Suerth JD; Barczak E; Heckl D; Levy C; Bernadin O; Charpentier E; Williams DA; Fehse B; Verhoeyen E; Schambach A
Biomaterials; 2016 Aug; 97():97-109. PubMed ID: 27162078
[TBL] [Abstract][Full Text] [Related]
18. Stable gammaretroviral vector expression during embryonic stem cell-derived in vitro hematopoietic development.
Ramezani A; Hawley TS; Hawley RG
Mol Ther; 2006 Aug; 14(2):245-54. PubMed ID: 16731046
[TBL] [Abstract][Full Text] [Related]
19. 3' self-inactivating long terminal repeat inserts for the modulation of transgene expression from lentiviral vectors.
Manic G; Maurin-Marlin A; Galluzzi L; Subra F; Mouscadet JF; Bury-Moné S
Hum Gene Ther Methods; 2012 Apr; 23(2):84-97. PubMed ID: 22456436
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.
Moiani A; Miccio A; Rizzi E; Severgnini M; Pellin D; Suerth JD; Baum C; De Bellis G; Mavilio F
PLoS One; 2013; 8(1):e55721. PubMed ID: 23383272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
